Two Molecularly Distinct G₂/M Checkpoints Are Induced by Ionizing Irradiation

REFERENCES

• Ahn, J. Y., J. K. Schwarz, H. Piwnica-Worms, and C. E. Canman. 2000. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Res. 60: 5934–5936.
   PubMed Web of Science ®Google Scholar
• Banin, S., L. Moyal, S. Shieh, Y. Taya, C. W. Anderson, L. Chessa, N. I. Smorodinsky, C. Prives, Y. Reiss, Y. Shiloh, and Y. Ziv. 1998. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281: 1674–1677.
   PubMed Web of Science ®Google Scholar
• Bao, S., R. S. Tibbetts, K. M. Brumbaugh, Y. Fang, D. A. Richardson, A. Ali, S. M. Chen, R. T. Abraham, and X. F. Wang. 2001. ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses. Nature 411: 969–974.
   PubMed Web of Science ®Google Scholar
• Beamish, H., and M. F. Lavin. 1994. Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int. J. Radiat. Biol. 65: 175–184.
   PubMed Web of Science ®Google Scholar
• Beamish, H., R. Williams, P. Chen, and M. F. Lavin. 1996. Defect in multiple cell cycle checkpoints in ataxia-telangiectasia postirradiation. J. Biol. Chem. 271: 20486–20493.
   PubMed Web of Science ®Google Scholar
• Canman, C. E., and M. B. Kastan. 1998. Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis. Oncogene 16: 957–966.
   PubMedGoogle Scholar
• Canman, C. E., D. S. Lim, K. A. Cimprich, Y. Taya, K. Tamai, K. Sakaguchi, E. Appella, M. B. Kastan, and J. D. Siliciano. 1998. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677–1679.
   PubMed Web of Science ®Google Scholar
• Enoch, T., A. M. Carr, and P. Nurse. 1992. Fission yeast genes involved in coupling mitosis to completion of DNA replication. Genes Dev. 6: 2035–2046.
   PubMed Web of Science ®Google Scholar
• Falck, J., N. Mailand, R. G. Syljuasen, J. Bartek, and J. Lukas. 2001. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 410: 842–847.
   PubMed Web of Science ®Google Scholar
• Flatt, P. M., and J. A. Pietenpol. 2000. Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery. Drug Metab. Rev. 32: 283–305.
   PubMed Web of Science ®Google Scholar
• Hartwell, L. H., and M. B. Kastan. 1994. Cell cycle control and cancer. Science 266: 1821–1828.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., and D. S. Lim. 2000. The many substrates and functions of ATM. Nat. Rev. Mol. Cell. Biol. 1: 179–186.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51: 6304–6311.
   PubMed Web of Science ®Google Scholar
• Kraakman-van der Zwet, M., W. J. Overkamp, A. A. Friedl, B. Klein, G. W. Verhaegh, N. G. Jaspers, A. T. Midro, F. Eckardt-Schupp, P. H. Lohman, and M. Z. Zdzienicka. 1999. Immortalization and characterization of Nijmegen breakage syndrome fibroblasts. Mutat. Res. 434: 17–27.
   PubMedGoogle Scholar
• Lim, D. S., S. T. Kim, B. Xu, R. S. Maser, J. Lin, J. H. Petrini, and M. B. Kastan. 2000. ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway. Nature 404: 613–617.
   PubMed Web of Science ®Google Scholar
• Matsuoka, S., M. Huang, and S. J. Elledge. 1998. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282: 1893–1897.
   PubMed Web of Science ®Google Scholar
• Matsuoka, S., G. Rotman, A. Ogawa, Y. Shiloh, K. Tamai, and S. Elledge. 2000. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl. Acad. Sci. USA 97: 10389–10394.
   PubMed Web of Science ®Google Scholar
• Maya, R., M. Balass, S. T. Kim, D. Shkedy, J. F. Leal, O. Shifman, M. Moas, T. Buschmann, Z. Ronai, Y. Shiloh, M. B. Kastan, E. Katzir, and M. Oren. 2001. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15: 1067–1077.
   PubMed Web of Science ®Google Scholar
• Melchionna, R., X. B. Chen, A. Blasina, and C. H. McGowan. 2000. Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nat. Cell Biol. 2: 762–765.
   PubMed Web of Science ®Google Scholar
• Morgan, S. E., C. Lovly, T. K. Pandita, Y. Shiloh, and M. B. Kastan. 1997. Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell. Biol. 17: 2020–2029.
   PubMed Web of Science ®Google Scholar
• Powell, S. N., J. S. DeFrank, P. Connell, M. Eogan, F. Preffer, D. Dombkowski, W. Tang, and S. Friend. 1995. Differential sensitivity of p53(−) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 55: 1643–1648.
   PubMed Web of Science ®Google Scholar
• Russell, K. J., L. W. Wiens, G. W. Demers, D. A. Galloway, S. E. Plon, and M. Groudine. 1995. Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Res. 55: 1639–1642.
   PubMed Web of Science ®Google Scholar
• Scott, D., A. R. Spreadborough, and S. A. Roberts. 1994. Radiation-induced G2 delay and spontaneous chromosome aberrations in ataxia-telangiectasia homozygotes and heterozygotes. Int. J. Radiat. Biol. 66: S157-S163.
   PubMed Web of Science ®Google Scholar
• Shiloh, Y. 1997. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet. 31: 635–662.
   PubMed Web of Science ®Google Scholar
• Siliciano, J. D., C. E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M. B. Kastan. 1997. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11: 3471–3481.
   PubMed Web of Science ®Google Scholar
• Slichenmyer, W., W. Nelson, R. Slebos, and M. B. Kastan. 1993. Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage. Cancer Res. 53: 4164–4168.
   PubMed Web of Science ®Google Scholar
• Tatsuka, M., O. Nikaido, K. Tatsumi, and H. Takebe. 1989. X-ray-induced G2 arrest in ataxia telangiectasia lymphoblastoid cells. Mutat. Res. 214: 321–328.
   PubMedGoogle Scholar
• Wang, Q., S. Fan, A. Eastman, P. J. Worland, E. A. Sausville, and P. M. O'Connor. 1996. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. J. Natl. Cancer Inst. 88: 956–965.
   PubMed Web of Science ®Google Scholar
• Weinert, T. 1988. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae. Science 241: 317–322.
   PubMed Web of Science ®Google Scholar
• Xu, B., S. T. Kim, and M. B. Kastan. 2001. Involvement of Brca1 in S-phase and G2-phase checkpoints after ionizing irradiation. Mol. Cell. Biol. 21: 3445–3450.
   PubMed Web of Science ®Google Scholar
• Yao, S. L., A. J. Akhtar, K. A. McKenna, G. C. Bedi, D. Sidransky, M. Mabry, R. Ravi, M. I. Collector, R. J. Jones, S. J. Sharkis, E. J. Fuchs, and A. Bedi. 1996. Selective radiosensitization of p53-deficient cells by caffeine-mediated activation of p34cdc2 kinase. Nat. Med. 2: 1140–1143.
   PubMed Web of Science ®Google Scholar
• Zampetti-Bosseler, F., and D. Scott. 1981. Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int. J. Radiat. Biol. 39: 547–558.
   Web of Science ®Google Scholar
• Zhao, S., Y. C. Weng, S. S. Yuan, Y. T. Lin, H. C. Hsu, S. C. Lin, E. Gerbino, M. H. Song, M. Z. Zdzienicka, R. A. Gatti, J. W. Shay, Y. Ziv, Y. Shiloh, and E. Y. Lee. 2000. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products. Nature 405: 473–477.
   PubMed Web of Science ®Google Scholar
• Zhou, B. B., and S. J. Elledge. 2000. The DNA damage response: putting checkpoints in perspective. Nature 408: 433–439.
   PubMed Web of Science ®Google Scholar